Li; Shulin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Li; Shulin.The latest application filed is for "large-scale axle intelligent cross wedge rolling mill for rail transit".

Company Profile

3.4.15

Li; Shulin - Houston TX
Li; Shulin - Taiyuan CN
Li; Shulin - Baton Rouge LA
Li, Shulin - Troy MI
LI, SHULIN - THE WOODLANDS TX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
T cells expressing membrane-anchored IL-12 for the treatment of cancer Grant 11,421,010 - Li , et al. August 23, 2	2022-08-23
Large-scale axle intelligent cross wedge rolling mill for rail transit App 20220136558 - Chu; Zhibing ; et al.	2022-05-05
Modified Il-12 T Cell Therapy For The Treatment Of Cancer App 20220118015 - LI; Shulin ; et al.	2022-04-21
Fgl2 Neutraling Cell Therapy And Methods Of Use Thereof App 20210393753 - LI; Shulin ; et al.	2021-12-23
Fgl2 Monoclonal Antibodies And Their Use In Treating Malignant Tumors App 20200055955 - LI; Shulin ; et al.	2020-02-20
T Cells Expressing Membrane-anchored Il-12 For The Treatment Of Cancer App 20200048322 - LI; Shulin ; et al.	2020-02-13
Specific detection tool for mesenchymal and epithelial-mesenchymal transformed circulating tumor cells Grant 10,329,353 - Satelli , et al.	2019-06-25
Carcinoma Homing Peptide (chp), Its Analogs, And Methods Of Using App 20170260246 - Li; Shulin ; et al.	2017-09-14
Carcinoma homing peptide (CHP), its analogs, and methods of using Grant 9,657,077 - Li , et al. May 23, 2	2017-05-23
Specific Detection Tool For Mesenchymal And Epithelial-mesenchymal Transformed Circulating Tumor Cells App 20160009812 - SATELLI; Arun ; et al.	2016-01-14
Carcinoma Homing Peptide (CHP), Its Analogs, and Methods of Using App 20120208770 - Li; Shulin ; et al.	2012-08-16
Polypeptide-Nucleic Acid Conjugate for Immunoprophylaxis or Immunotherapy for Neoplastic or Infectious Disorders App 20090123467 - Bedi; Atul ; et al.	2009-05-14
Prognosis and Systemic Therapy for Treating Malignancy App 20070280905 - Li; Shulin ; et al.	2007-12-06
Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders App 20070212337 - Bedi; Atul ; et al.	2007-09-13
Gene expression levels as predictors of chemoradiation response of cancer App 20060037088 - Li; Shulin	2006-02-16
Apparatus and method for predicting treatment response of cancer App 20030175717 - Li, Shulin ; et al.	2003-09-18
Formulations For Electroporation App 20020102729 - MACLAUGHLIN, FIONA ; et al.	2002-08-01
Formulations for electroporation App 20020025578 - MacLaughlin, Fiona ; et al.	2002-02-28

Company Registrations

NCAGE Code	44X70	LI SHULIN
CAGE Code	44X70	LI, SHULIN

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.